For the past five years, Stag Liuzza has litigated cases on behalf of women who suffered permanent alopecia, or hair loss, as a result of receiving a breast cancer chemotherapy drug called Taxotere. Plaintiffs claim that the manufacturers of the drug, including Sanofi-Aventis U.S., L.L.C. (“Sanofi”) and approximately twelve other pharmaceutical companies, failed to warn users of this side effect.

Taxotere Cases are pending in the EDLA

The cases are consolidated in the Eastern District of Louisiana in New Orleans and have been under the purview of two different judges. Plaintiffs have fought a long uphill battle with two cases being tried and both resulting in defense verdicts. In the first, the jury found that the plaintiff did not have permanent chemotherapy induced alopecia due to Taxotere. In the second, the jury concluded that the plaintiff failed to prove Sanofi did not take reasonable care to warn plaintiff’s prescribing physicians about the risk of hair loss associated with Taxotere. Both plaintiffs appealed.

Taxotere Appeal Gives Case New Life

Recently, plaintiffs received a glimmer of hope in the litigation when the 5th Circuit Court of Appeals overturned the first aforementioned jury verdict in favor of Sanofi, and remanded the case for a new trial.

The Court of Appeals found that the trial court erroneously permitted two of Sanofi’s witnesses to offer evidence and testify that the risk of alopecia was small after Taxotere use. The first witness was a corporate representative and former vice president of Sanofi and the second was an expert. Essentially, the Court of Appeals found that because the corporate representative was not qualified as an expert, his scientific opinion should not have been allowed. It also ruled that the expert’s testimony should not have been admitted because those opinions relied on the corporate representative’s testimony. Further, the fact that the inadmissible opinions were featured in Sanofi’s closing arguments detrimentally prejudiced the plaintiff. Hence, a new trial.

We are hopeful that this decision is a sign of good things to come in the Taxotere litigation and we are able to obtain justice for the thousands of women injured by Sanofi’s wrongdoing.

If you or someone you know has been injured by a medical device or pharmaceutical, contact Stag Liuzza, LLC for a free consultation at 505-593-9600.

OUR team

We prefer doing to talking (except in court), We take the bull by the horns and give you clear and practical advice. Personal, to the point, and in plain language. Any questions? Feel free to call or to drop by.

After reviewing your medical costs, lost wages, and pain and suffering damages, we can help you understand what your case is worth and plan a road map going forward.
After reviewing your medical costs, lost wages, and pain and suffering damages, we can help you understand what your case is worth and plan a road map going forward.

$1.056 billion verdict against Exxon Mobil

If you think you may have a claim and need legal help to hold those parties responsible for damage that they have caused, contact an attorney from our firm.

Stag Liuzza fights industry giants across the country and holds them accountable for their actions. We strive to ensure that communities have access to safe drinking water, clean air, and a healthy environment. is operated and provided by Stag Liuzza, LLC responsible attorneys Michael G. Stag and Ashley M. Liuzza. Stag Liuzza, LLC is officed in New Orleans, LA, and our attorneys are licensed in Louisiana and Mississippi.

Nothing on this site should be taken to establish an attorney-client relationship with us unless and until a contract for representation is signed. The attorneys of Stag Liuzza are licensed in Louisiana and Mississippi and may associate counsel licensed in other jurisdictions as necessary.

Past results do not guarantee any similar result or outcome in your claim. Each claim is different.

This website uses cookies to ensure you get the best experience on our website.